Congress 117 - HR 5657 - Medical Marijuana Research Act

Sponsor

Cosponsors

Topics

Administrative law and regulatory procedures Alternative treatments Department of Health and Human Services Drug safety, medical device, and laboratory regulation Drug therapy Drug trafficking and controlled substances Food and Drug Administration (FDA) Health Health personnel Licensing and registrations Medical research Research administration and funding

Full Text

View Full Bill Text

Votes

Summary

Medical Marijuana Research Act

This bill establishes a new, separate registration process to facilitate medical marijuana research.

Specifically, it directs the Drug Enforcement Administration to register (1) practitioners to conduct medical marijuana research, and (2) manufacturers and distributors to supply marijuana for such research.

Additionally, the Department of Health and Human Services must continue to produce marijuana through the National Institute on Drug Abuse Drug Supply Program and implement a specialized process for supplying marijuana products available through state-authorized marijuana programs to researchers until manufacturers and distributors can provide a sufficient supply of marijuana for medical research.

Actions

Apr 5, 2022

Received in the Senate.
Apr 4, 2022

Motion to reconsider laid on the table Agreed to without objection.
Apr 4, 2022

On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 343 - 75 (Roll no. 108). (text: CR H4136-4138)
Apr 4, 2022

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 343 - 75 (Roll no. 108).(text: CR H4136-4138)
Apr 4, 2022

Considered as unfinished business. (consideration: CR H4144-4145)
Apr 4, 2022

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Apr 4, 2022

DEBATE - The House proceeded with forty minutes of debate on H.R. 5657.
Apr 4, 2022

Considered under suspension of the rules. (consideration: CR H4136-4140)
Apr 4, 2022

Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Oct 22, 2021

Referred to the Subcommittee on Health.
Oct 21, 2021

Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 21, 2021

Sponsor introductory remarks on measure. (CR E1126)
Oct 21, 2021

Introduced in House

Amendments

Related Bills